Ajanta Pharma's Board has approved a 1st interim dividend for FY 2026. Shareholders will receive ₹28 per share, resulting in a total payout of ₹349.82 Cr.

A record date has been set to determine eligible shareholders, with dividend payments to follow shortly after.

This action signals consistent shareholder returns and is a positive update for investors.